EXTRACTION OF PHYSOSTIGMINE FROM BIOLOGIC FLUIDS AND ANALYSIS BY LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION

被引:7
作者
LAWRENCE, GD
YATIM, N
机构
[1] From the Chemistry Department, Long Island University, Brooklyn
来源
JOURNAL OF PHARMACOLOGICAL METHODS | 1990年 / 24卷 / 02期
关键词
Cerebrospinal fluid; Cyano column extraction; Electrochemical detection; High-performance liquid chromatography; Physostigmine; Plasma;
D O I
10.1016/0160-5402(90)90024-F
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A rapid and simple method is described for the extraction of physostigmine (Phy) and its hydrolysis product, eseroline, from plasma, whole blood, and cerebrospinal fluid (CSF) and their subsequent quantitation by high-performance liquid chromatography (HPLC) with dual electrode electrochemical detection. Phy and eseroline were extracted from biologic fluids with cyano-phase columns eluted with 0.1 M citrate buffer, pH 4 containing 20% acetonitrile. Phy recovery from citrate buffer and CSF was nearly 100%. Phy recovery from plasma was 82% when methanol was used to precipitate proteins and 62% when HCIO4 was used to precipitate proteins. Phy recovery from whole blood was only 17%. These results are discussed in the context of attempting to measure Phy in fluids of patients receiving this drug in clinical trials for the treatment of Alzheimer's disease. © 1990.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 11 条
[1]   INHIBITION OF ACETYLCHOLINESTERASE FROM ELECTRIC-EEL BY (-)-PHYSOSTIGMINE AND (+)-PHYSOSTIGMINE AND RELATED-COMPOUNDS [J].
BROSSI, A ;
SCHONENBERGER, B ;
CLARK, OE ;
RAY, R .
FEBS LETTERS, 1986, 201 (02) :190-192
[2]   PHYSOSTIGMINE - IMPROVEMENT OF LONG-TERM-MEMORY PROCESSES IN NORMAL HUMANS [J].
DAVIS, KL ;
MOHS, RC ;
TINKLENBERG, JR ;
PFEFFERBAUM, A ;
KOPELL, BS ;
HOLLISTER, LE .
SCIENCE, 1978, 201 (4352) :272-274
[3]   DETERMINATION OF PHYSOSTIGMINE IN PLASMA BY LIQUID-CHROMATOGRAPHY WITH DUAL ELECTRODE AMPEROMETRIC DETECTION [J].
ISAKSSON, K ;
KISSINGER, PT .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1987, 10 (10) :2213-2229
[4]  
MOHS RC, 1985, AM J PSYCHIAT, V142, P28
[5]  
ROSENBERRY TL, 1984, J BIOL CHEM, V259, P5643
[6]   LONG-TERM ADMINISTRATION OF ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE [J].
STERN, Y ;
SANO, M ;
MAYEUX, R .
NEUROLOGY, 1988, 38 (12) :1837-1841
[7]   EFFECTS OF ORAL PHYSOSTIGMINE IN ALZHEIMERS-DISEASE [J].
STERN, Y ;
SANO, M ;
MAYEUX, R .
ANNALS OF NEUROLOGY, 1987, 22 (03) :306-310
[8]  
THAL LJ, 1983, NEW ENGL J MED, V308, P720
[9]   CHRONIC ORAL PHYSOSTIGMINE WITHOUT LECITHIN IMPROVES MEMORY IN ALZHEIMERS-DISEASE [J].
THAL, LJ ;
MASUR, DM ;
BLAU, AD ;
FULD, PA ;
KLAUBER, MR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1989, 37 (01) :42-48
[10]   BINDING OF PHYSOSTIGMINE TO RAT AND HUMAN-PLASMA AND CRYSTALLINE SERUM ALBUMINS [J].
UNNI, LK ;
SOMANI, SM .
LIFE SCIENCES, 1985, 36 (14) :1389-1396